March 2026
The global over the counter (OTC) test market size is estimated to hit around USD 69.23 billion by 2035 increasing from USD 24.69 billion in 2025, with a CAGR of 10.86%.
June 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
June 2026
The U.S. over the counter (OTC) drugs market size is expected to increase from USD 24.81 billion in 2025 and is predicted to hit USD 46.67 billion by 2035, with a CAGR of 6.52%.
January 2026
The global over-the-counter (OTC) analgesics market size was valued USD 31.89 billion in 2025 and is estimated to hit around USD 45.77 billion by 2035 with a CAGR of 3.68%.
May 2026
The global power over Ethernet market size is expected to increase from USD 1.64 billion in 2025 to hit around USD 4.87 billion by 2035, growing at a CAGR of 11.50%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
March 2026
The global power over ethernet chipsets market size was evaluated at USD 0.99 billion in 2025 and is predicted to hit around USD 3.14 billion by 2035, growing at a CAGR of 12.24%.
February 2026
The global automotive OTA (over-the-air) enablement component market size is estimated to hit around USD 15.94 billion by 2035 increasing from USD 4.80 billion in 2025, with a CAGR of 12.75%.
December 2025
The over the top (OTT) market size is accounted at USD 399.12 billion in 2025 and is projected to surpass around USD 2816.85 billion by 2034 with a CAGR of 24.42%.
July 2025
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 548.55 million in 2024, with a CAGR of 7.34%.
August 2025
The global cardiotoxicity screening market size is estimated to hit around USD 8.46 billion by 2034 increasing from USD 2.84 billion in 2024, with a CAGR of 11.54%.
July 2025
The global self-monitoring blood glucose devices market size is expected to hit around USD 33.30 billion by 2034 from USD 11.27 billion in 2024, with a CAGR of 11.44%.
June 2026
The global automated test equipment market size is exhibited at USD 7.63 billion in 2025 and is projected to hit around USD 12.04 billion by 2035, at a CAGR of 4.7%.
June 2026
The global gene therapy market size was exhibited at USD 11.07 billion in 2025 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
June 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The US cell and gene therapy market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 20.00 billion by 2035, growing at a CAGR of 17.21%.
June 2026
The global normothermic machine perfusion market size was estimated at USD 2.02 billion in 2025 and is expected to hit around USD 10.27 billion by 2035, growing at a CAGR of 17.66%.
June 2026
The global monocyte activation test market size surpass USD 687.99 million in 2025 and is projected to cross around USD 2,927.03 million by 2035 with a CAGR of 15.58% from 2026 to 2035.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
June 2026
The global phage therapy market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.92 billion by 2035, growing at a CAGR of 4.06%.
June 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global psychedelic therapeutics market size is estimated to hit around USD 12.40 billion by 2035 increasing from USD 2.94 billion in 2025, with a CAGR of 15.48%.
June 2026
The US stroke diagnostic and therapeutic market size was evaluated at USD 6.40 billion in 2025 and is predicted to hit around USD 15.04 billion by 2035, growing at a CAGR of 8.92%.